stella
beta
Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency — Stella
Recruiting
Back to Total Bilateral Limbal Cell Deficiency trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
France
Ophthalmology department, Edouard Herriot hospital, Hospices Civils de Lyon, Lyon
View full record on ClinicalTrials.gov